Texas · 89th Legislature (2025) · Bill

HB 3717: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

In committee Last action May 12, 2025: Laid on the table subject to call

Plain-language summary

HB 3717 is a bill introduced in the Texas House on March 4, 2025. According to its official title, it concerns: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy. Primary sponsor: Cody Harris (Republican), Jeff Leach (Republican), Dade Phelan (Republican), Angelia Orr (Republican), VanDeaver. It lists 29 additional sponsors. Most recent recorded action (May 12, 2025): Laid on the table subject to call.

Plain-language summary

Sponsors